Literature DB >> 24851102

Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011.

Kyu-Won Jung1, Young-Joo Won1, Hyun-Joo Kong1, Chang-Mo Oh1, Duk Hyoung Lee2, Jin Soo Lee3.   

Abstract

PURPOSE: This study aimed to report nationwide cancer statistics in Korea, including incidence, mortality, survival, and prevalence, and their trends.
MATERIALS AND METHODS: Incidence data from 1993 to 2011 were obtained from the Korea National Cancer Incidence Database, and vital status was followed through December 31, 2012. Mortality data from 1983 to 2011 were obtained from Statistics Korea. Crude and age-standardized rates for incidence, mortality, and prevalence, and relative survival were calculated.
RESULTS: A total of 218,017 cancer cases and 71,579 cancer deaths were reported to have occurred in 2011, and there were 1,097,253 prevalent cases identified in Korea as of January 1, 2012. Over the past 13 years (1999-2011), overall incidence rates have increased by 3.4% per year. The incidence rates of liver and cervical cancers have decreased, while those of thyroid, breast, prostate, and colorectal cancers have increased. Notably, thyroid cancer increased by 23.3% per year in both sexes, and became the most common cancer since 2009. The mortality for all cancers combined decreased by 2.7% per year from 2002 to 2011. Five-year relative survival rates of patients diagnosed in the last 5 years (2007-2011) have improved by 25.1% compared with those from 1993 to 1995.
CONCLUSION: Overall cancer mortality rates have declined since 2002 in Korea, while incidence has increased rapidly and survival has improved.

Entities:  

Keywords:  Incidence; Korea; Mortality; Neoplasms; Prevalence; Survival

Year:  2014        PMID: 24851102      PMCID: PMC4022819          DOI: 10.4143/crt.2014.46.2.109

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN: 1598-2998            Impact factor:   4.679


  10 in total

1.  [Index for evaluating completeness of registration in population-based cancer registries and estimation of registration rate at the Osaka Cancer Registry between 1966 and 1992 using this index].

Authors:  W Ajiki; H Tsukuma; A Oshima
Journal:  Nihon Koshu Eisei Zasshi       Date:  1998-10

2.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

Review 3.  Interpreting trends in cancer patient survival.

Authors:  P W Dickman; H-O Adami
Journal:  J Intern Med       Date:  2006-08       Impact factor: 8.989

4.  Current status of thyroid cancer screening in Korea: results from a nationwide interview survey.

Authors:  Mi Ah Han; Kui Son Choi; Hoo-Yeon Lee; Yeonju Kim; Jae Kwan Jun; Eun-Cheol Park
Journal:  Asian Pac J Cancer Prev       Date:  2011

5.  Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database.

Authors:  Hai-Rim Shin; Young-Joo Won; Kyu-Won Jung; Hyun-Joo Kong; Seon-Hee Yim; Jung-Kyu Lee; Hong-In Noh; Jong-Koo Lee; Paola Pisani; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2005-12-31       Impact factor: 4.679

6.  Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis.

Authors:  A Gondos; F Bray; T Hakulinen; H Brenner
Journal:  Ann Oncol       Date:  2008-12-09       Impact factor: 32.976

7.  Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005.

Authors:  Lindsey Enewold; Kangmin Zhu; Elaine Ron; Aizen J Marrogi; Alexander Stojadinovic; George E Peoples; Susan S Devesa
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-24       Impact factor: 4.254

8.  Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010.

Authors:  Kyu-Won Jung; Young-Joo Won; Hyun-Joo Kong; Chang-Mo Oh; Hong Gwan Seo; Jin-Soo Lee
Journal:  Cancer Res Treat       Date:  2013-03-31       Impact factor: 4.679

9.  Measuring the burden of disease in Korea.

Authors:  Seok-Jun Yoon; Sang-Cheol Bae; Sang-Il Lee; Hyejung Chang; Heui Sug Jo; Joo-Hun Sung; Jae-Hyun Park; Jin-Yong Lee; Youngsoo Shin
Journal:  J Korean Med Sci       Date:  2007-06       Impact factor: 2.153

10.  Cancer survival in Korea 1993-2002: a population-based study.

Authors:  Kyu Won Jung; Seon Hee Yim; Hyun Joo Kong; Soon Young Hwang; Young Joo Won; Jong Koo Lee; Hai Rim Shin
Journal:  J Korean Med Sci       Date:  2007-09       Impact factor: 2.153

  10 in total
  173 in total

1.  Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.

Authors:  Anna Song; Wankyu Eo; Sookyung Lee
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

2.  Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.

Authors:  Jeong Mo Bae; Tae Hun Lee; Nam-Yun Cho; Tae-You Kim; Gyeong Hoon Kang
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

3.  Feasibility of terahertz reflectometry for discrimination of human early gastric cancers.

Authors:  Young Bin Ji; Chan Hyuk Park; Hyunki Kim; Sang-Hoon Kim; Gyu Min Lee; Sam Kyu Noh; Tae-In Jeon; Joo-Hiuk Son; Yong-Min Huh; Seungjoo Haam; Seung Jae Oh; Sang Kil Lee; Jin-Suck Suh
Journal:  Biomed Opt Express       Date:  2015-03-23       Impact factor: 3.732

4.  The dynamics of cancer burden in Asia.

Authors:  Kota Katanoda
Journal:  Ann Transl Med       Date:  2014-07

5.  Oral signs of acute leukemia for early detection.

Authors:  Hyun-Chang Lim; Chang-Sung Kim
Journal:  J Periodontal Implant Sci       Date:  2014-12-31       Impact factor: 2.614

6.  Information-sharing challenges between adolescents with cancer, their parents and health care providers: a qualitative study.

Authors:  Masoud Bahrami; Mahboobeh Namnabati; Fariborz Mokarian; Parastoo Oujian; Paul Arbon
Journal:  Support Care Cancer       Date:  2017-01-11       Impact factor: 3.603

7.  Comparison of compliance of adjuvant chemotherapy between laparoscopic and open surgery in patients with colon cancer.

Authors:  Kan Ho Chun; Byung Noe Bae; Hoon An; Hyeonseok Jeong; Hyunjin Cho; Geumhee Gwak; Keun Ho Yang; Ki Hwan Kim; Hong Ju Kim; Young Duk Kim
Journal:  Ann Coloproctol       Date:  2014-12-31

8.  Prognostic relevance of genetic variants involved in immune checkpoints in patients with colorectal cancer.

Authors:  Shinkyo Yoon; Byung Woog Kang; Su Yeon Park; Hye Jin Kim; Jun Seok Park; Gyu Seog Choi; Jong Gwang Kim
Journal:  J Cancer Res Clin Oncol       Date:  2016-06-23       Impact factor: 4.553

9.  Clinicopathologic risk factors for right paraesophageal lymph node metastasis in patients with papillary thyroid carcinoma.

Authors:  Q A Yu; D K Ma; K P Liu; P Wang; C M Xie; Y H Wu; W J Dai; H C Jiang
Journal:  J Endocrinol Invest       Date:  2018-03-17       Impact factor: 4.256

10.  High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer.

Authors:  Ji Soo Park; Hong Jae Chon; Hei-Cheul Jeung; Sang Joon Shin; Sun Young Rha; Joong Bae Ahn; Kang Young Lee; Nam Kyu Kim; Hyun Cheol Chung
Journal:  J Cancer Res Clin Oncol       Date:  2016-07-22       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.